Related Experiment Video
Updated: Jan 21, 2026
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
A patent review of RAF kinase inhibitors (2010-2018)
Ruo-Jun Man1,2, Ya-Liang Zhang1, Ai-Qin Jiang1
1State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University , Nanjing , People's Republic of China.
Abstract:
Introduction: RAF kinase inhibitors block and regulate RAS/RAF/MEK/ERK signaling, which is a key to tumor treatment. At present, although RAF kinase inhibitors have good efficacy, there are few such drugs with low toxicity, and thus, it is urgent to find novel RAF kinase inhibitors associated with higher activity and fewer adverse reactions. This review highlights the anti-tumor effects of several published RAF kinase inhibitors and might be helpful in providing new ideas for the development of novel drug candidates in the future. Areas covered: This article covers the pertinent literature published on RAF kinase inhibitors from 2010 to 2018, as well as the potential use of these compounds as therapeutics for cancer. Expert opinion: To date, many RAF kinase inhibitors with different structures have been studied, many of which have prominent inhibitory activities toward RAF kinase. Further, the specificity of these drugs offers hope for the targeted therapy of tumors. Although RAF kinase inhibition has achieved promising results for the treatment of many cancers, overcoming limitations associated with drug resistance and safety comprises a new direction for the optimization and improvement of RAF kinase inhibitors.
Insights
Novel RAF kinase inhibitors are crucial for cancer treatment due to their anti-tumor effects. Research focuses on developing drugs with higher activity and fewer adverse reactions for targeted cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- The RAS/RAF/MEK/ERK signaling pathway is a critical target in cancer treatment.
- Current RAF kinase inhibitors show efficacy but often have limitations in toxicity and adverse reactions.
- There is an urgent need for novel RAF kinase inhibitors with improved activity and safety profiles.
Purpose of the Study:
- To review the anti-tumor effects of published RAF kinase inhibitors.
- To explore the potential of these compounds in cancer therapeutics.
- To provide insights for the development of new drug candidates.
Main Methods:
- Literature review of published research on RAF kinase inhibitors from 2010 to 2018.
- Analysis of anti-tumor effects and therapeutic potential.
- Evaluation of drug resistance and safety limitations.
Main Results:
- Numerous RAF kinase inhibitors with diverse structures exhibit potent inhibitory activity.
- The specificity of these inhibitors offers promise for targeted cancer therapy.
- Promising results have been observed in various cancer treatments.
Conclusions:
- RAF kinase inhibitors are vital for cancer therapy, with ongoing research focusing on enhancing efficacy and reducing toxicity.
- Overcoming drug resistance and improving safety are key future directions for RAF kinase inhibitor optimization.
- Further development of these targeted therapies holds significant potential for improved cancer treatment outcomes.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
01:10Review and Preview
Percentiles are a type of fractile that partition data into...
01:13Review and Preview
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:52Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...